Regarding thrombophilia, in patients with no thrombotic recurrence, 6 of them were positive for the FV Leiden mutation and 3 for the PT20210A mutation, all of them in heterozygosis. This evidence concerns the gene F5 and Rare hereditary thrombophilia.